Interpretation of surgical update in 2018 Japanese Clinical Practice Guidelines for Thyroid Tumors / 中国实用外科杂志

ABSTRACT

The incidence of thyroid cancer has increased all over the world in recent years,which has become a hot issue of widespread concern.Surgery is an important means for the treatment of thyroid cancer.Standard surgical treatment can effectively improve the prognosis and quality of life of patients,while non-standard surgical treatment can increase the risk of recurrence,reduce the survival rate,and bring serious physiological,psychological and economic burden to patients.In order to standardize the diagnosis and treatment of thyroid cancer and improve the prognosis of patients,many guidelines have been issued at home and abroad.With the application of new therapies and the emergence of new clinical evidences,guidelines are constantly updated in various countries,the most representative of which are the guidelines issued by the American Thyroid Association and the National Comprehensive Cancer Network.In the past,surgeons paid more attention to the European and American guidelines,but little was known about the treatment of thyroid cancer in neighbouring Japan. Following the publication of the first edition of Japanese Clinical Practice Guidelines for Thyroid Tumors in 2010,Japan formally released a revised edition of the old edition of the guidelines in 2018. Compared with the old version,the recommendations of the new version are more comprehensive and accurate,including risk stratification of papillary cancer and indications of primary lesion resection and lymph node dissection in patients with different risk stratification,principles of primary and complementary surgery for follicular carcinoma of different histological types,and principles of treatment for hereditary and sporadic medullary carcinoma,etc.